Canada markets open in 7 hours 34 minutes

Santen Pharmaceutical Co., Ltd. (4536.T)

Tokyo - Tokyo Delayed Price. Currency in JPY
Add to watchlist
1,640.00+13.00 (+0.80%)
As of 02:35PM JST. Market open.
Currency in JPY

Valuation Measures4

Market Cap (intraday) 584.75B
Enterprise Value 489.79B
Trailing P/E 22.48
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.98
Price/Book (mrq)1.91
Enterprise Value/Revenue 1.62
Enterprise Value/EBITDA 9.66

Trading Information

Stock Price History

Beta (5Y Monthly) 0.25
52-Week Change 332.76%
S&P500 52-Week Change 323.20%
52 Week High 31,670.00
52 Week Low 31,165.50
50-Day Moving Average 31,573.48
200-Day Moving Average 31,457.30

Share Statistics

Avg Vol (3 month) 31.45M
Avg Vol (10 day) 31.16M
Shares Outstanding 5359.4M
Implied Shares Outstanding 6372.14M
Float 8348.73M
% Held by Insiders 12.79%
% Held by Institutions 150.24%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 434
Forward Annual Dividend Yield 42.09%
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 42.10
Payout Ratio 445.60%
Dividend Date 3N/A
Ex-Dividend Date 4Sept 27, 2024
Last Split Factor 25:1
Last Split Date 3Mar 27, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 8.82%
Operating Margin (ttm)3.01%

Management Effectiveness

Return on Assets (ttm)5.62%
Return on Equity (ttm)8.92%

Income Statement

Revenue (ttm)301.96B
Revenue Per Share (ttm)823.04
Quarterly Revenue Growth (yoy)-0.20%
Gross Profit (ttm)N/A
EBITDA 56.72B
Net Income Avi to Common (ttm)26.64B
Diluted EPS (ttm)72.40
Quarterly Earnings Growth (yoy)-97.40%

Balance Sheet

Total Cash (mrq)94.96B
Total Cash Per Share (mrq)261.62
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.55
Book Value Per Share (mrq)843.19

Cash Flow Statement

Operating Cash Flow (ttm)72.65B
Levered Free Cash Flow (ttm)50.53B